🔗 Share this article

Grammy-winning R&B singer D’Angelo died on October 14 at 51 years old after a private battle with pancreatic malignancy.

“The brilliant light of our family has dimmed his light for us in the present world,” his family stated. “After a prolonged and courageous struggle with the disease, we are heartbroken to announce that D’Angelo, recognized by his fans around the globe as D’Angelo, has been taken from us.”

D’Angelo left an indelible mark on music with his innovative modern soul style and collaborations with renowned musicians.

He launched his first record, “Brown Sugar,” in the mid-nineties to immediate acclaim. The record reached No. 4 on Billboard’s Top R&B Albums chart, went platinum soon after, and received several award nominations.

However, it was his second album, “Voodoo,” in 2000 that propelled his music career into the limelight. The album premiered at the top spot on both the R&B charts and the main album chart. He won two Grammys: Best R&B Album and Best Male R&B Vocal Performance for “Untitled (How Does It Feel).”

The music video for “Untitled (How Does It Feel)” solidified D’Angelo’s reputation as a sex symbol, albeit a reluctant one, in the public consciousness. The personal depiction featured the singer, notably bare to his waist, performing directly into the camera.

D’Angelo stepped back from the public eye after putting out Voodoo and publicly struggled with substance abuse. In 2005, he was part of a serious vehicle accident that put him in grave health.

Over ten years later, his last record, “Black Messiah” (2014), confirmed his lasting popularity with another top chart entry on the R&B chart and a award for Top R&B Record.

Once more, in his own mysterious way, D’Angelo had limited public outings in the following years.

The singer was announced as a headliner for the 2025 Roots Picnic festival, but his appearance was canceled, citing an “unforeseen medical delay.”

Even though information is limited about D’Angelo’s well-being in the weeks leading up to his death, he had reportedly been in the hospital for months and in hospice for two weeks.

D’Angelo’s demise is a clear example of the harmful impact of pancreatic cancer, one of the most deadly and least preventable types of the disease, on a brilliant talent whose existence was ended too soon.

“We are saddened that he can only provide dear memories with his loved ones, but we are eternally grateful for the legacy of deeply emotional music he has left us,” his family expressed.

Pancreatic Cancer: Lethal and Rarely Preventable

Pancreatic cancer affects the digestive organ, a tiny gland that produces insulin and is vital in breaking down food, among other functions. The position and dimensions of the organ in the human system make it more challenging to identify cancer.

Even though this cancer makes up only about 3% of cancer diagnoses each year in the United States, it is responsible for 7% of malignancy fatalities.

Nearly 70,000 individuals will be found to have pancreatic cancer and about 52,000 will succumb to the illness in 2025.

“Pancreatic cancer is one of the most lethal diseases, with an fast-growing mass and dismal outcomes. We have few and poor treatment options, and a narrow opportunity to make a meaningful impact on the well-being of people,” said a medical oncologist.

Since this disease seldom produces initial signs, it’s frequently identified only once the condition is advanced. Even when a individual has symptoms they are often vague and may be mistaken for a several common illnesses.

“Currently, there is no good way to detect this malignancy in the initial phases, apart from paying attention to physical changes and speaking with your doctor if there are new or unusual signs,” said a health expert.

Frequent indicators of this disease include:

• abdominal or lower back pain
• weight loss
• jaundice
• reduced hunger
• brownish urine
• light-colored or greasy stools
• loose stools
• increased appetite or thirst
• nausea

At 51 years old, D’Angelo’s demise is an exception, as this malignancy is most common in adults in the 65 to 75 age bracket. However, many cancers, such as this type, have become more common among younger adults.

“Pancreatic cancer identified before the age of 50 is deemed rare, yet concerningly, doctors are noticing a growing number of younger patients suffering from this condition,” said a expert.

Family History Affects Cancer Risk

In the absence of reliable detection methods for pancreatic cancer, professionals stressed the significance of knowing your relatives’ health background. Some contributing elements, such as tobacco use and obesity also have an influence in the onset of this disease.

Black individuals have the highest incidence of this malignancy in the United States and are more prone to be diagnosed with inoperable cancer.

“The first step toward reducing one’s risk of pancreatic cancer is understanding personal risk factors. People should examine their genetic background, hereditary factors, and health issues, such as diabetes, long-term pancreas inflammation, or overweight that may increase their susceptibility,” advised a specialist.

Inherited genetic risk factors are linked to as much as 10% of all pancreatic cancer instances. If a relative in your family has had pancreatic cancer, you may want to consider genetic testing.

“For people with a family history of pancreatic cancer or those carrying high risk genetic mutations, screening may involve advanced imaging such as MRI scans or endoscopic ultrasound (EUS) to find initial alterations in the pancreas,” he clarified.

For those wishing to lower their chance, habit adjustments may make a difference. The best step you can take to lower your risk of this disease is to quit smoking, and if you are a non-smoker, stay away altogether.

Heavy drinking is linked to pancreas inflammation, a contributing element for pancreatic cancer, so limiting or avoiding drinks may help lower your chance.

Managing your weight or shedding pounds may also aid reduce your risk. Individuals with excess weight are 20% more likely to get this disease. This malignancy also is more frequent in people with diabetes, and reducing weight can also reduce the chance of type 2 diabetes.

In spite of this disease’s poor prognosis, there is still hope.

“We are making progress with therapies and more recent mixed drug treatments. There are emerging precision medicines that already are showing results,” said a specialist.

For numerous people, however, education about this rare but {dev